A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA
| Status: | Completed |
|---|---|
| Conditions: | Influenza |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any - 9 |
| Updated: | 5/25/2018 |
| Start Date: | August 2009 |
| End Date: | April 2010 |
A Phase II, Multicenter, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population
The purpose of this study is to evaluate the immunogenicity and safety profile of CSL425
(CSL's 2009 H1N1 influenza vaccine) in a healthy pediatric population.
(CSL's 2009 H1N1 influenza vaccine) in a healthy pediatric population.
Inclusion Criteria:
- Male or female aged >= 6 months to < 9 years at the time of the first study
vaccination.
- For children < 3 years of age at the time of first vaccination, born at or after 36
weeks gestation.
Exclusion Criteria:
- Known hypersensitivity to a previous dose of influenza virus vaccine or allergy to
eggs, chicken protein, neomycin, polymyxin, or any components of the Study Vaccine
We found this trial at
13
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials